Humana has sued the Centers for Medicare and Medicaid Services over the results of the 2025 Medicare Advantage and Part D Star Ratings.
A new national survey shows more than 90% of independent pharmacists may not sell drugs for which the Medicare Part D program is trying to negotiate lower prices.
Elevance Health President and CEO Gail Boudreaux said the insurer is “considering all of our options” regarding the Centers for Medicare and Medicaid Services’ 2025 Medicare Advantage Star Ratings, which saw the company take a hit in its star ratings.